[Aldosterone antagonist therapy for chronic heart failure]

Nihon Naika Gakkai Zasshi. 2005 Feb 10;94(2):262-9. doi: 10.2169/naika.94.262.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Aldosterone / biosynthesis
  • Aldosterone / physiology
  • Chronic Disease
  • Death, Sudden, Cardiac / prevention & control
  • Diuretics / therapeutic use
  • Eplerenone
  • Fibrosis / etiology
  • Heart Failure / drug therapy*
  • Heart Failure / etiology
  • Heart Failure / physiopathology
  • Humans
  • Mineralocorticoid Receptor Antagonists / therapeutic use*
  • Myocardium / pathology
  • Randomized Controlled Trials as Topic
  • Spironolactone / analogs & derivatives*
  • Spironolactone / therapeutic use*
  • Sulfonamides / therapeutic use
  • Torsemide
  • Ventricular Remodeling

Substances

  • Diuretics
  • Mineralocorticoid Receptor Antagonists
  • Sulfonamides
  • Spironolactone
  • Aldosterone
  • Eplerenone
  • Torsemide